drugset / Trial / NCT05930028
A Study to Evaluate the Efficacy and Safety of BR1017A and BR1017B Combination Therapy in Essential Hypertension Patients With Primary Hypercholesterolemia
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective of this clinical study is to evaluate the efficacy and safety by comparing BR1017A+BR1017B treatment group to BR1017A treatment group and BR1017B treatment group respectively at Week 8 in essential hypertension patients with primary hypercholesterolemia
Timeline
- Start
- 2023-07-13
- Primary completion
- 2024-09-05
- Completion
- 2024-09-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atorvastatin | Small molecule | — | — |
| Subject | Ezetimibe | Unknown | — | — |
| Subject | Fimasartan | Small molecule | — | — |